v3.26.1
Summary of Significant Accounting Policies - Additional Information (Details)
$ in Millions
 6 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
Segment
Financial_Institution
Dec. 31, 2025
Summary Of Significant Accounting Policies [Line Items]    
Number of reportable segments 1  
Number of operating segments 1  
Number of financial institutions cash is held | Financial_Institution 2  
Change in Accounting Principle, Accounting Standards Update, Adopted [true false] true  
Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false] true  
Change in Accounting Principle, Accounting Standards Update, Adoption Date Jan. 01, 2026  
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] true  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2025-10 [Member]  
Otsuka Pharmaceutical Co., Ltd | Collaboration and License Agreements    
Summary Of Significant Accounting Policies [Line Items]    
Estimated cost sharing and reimbursement amount due | $ $ 4.6  
Accounts Receivable | Credit Concentration Risk | Customer    
Summary Of Significant Accounting Policies [Line Items]    
Concentration risk, percentage 0.00% 0.00%